SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BMRA (Biomerica)
BMRA 2.545-0.7%Nov 6 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeffrey L. Henken who wrote (36)5/15/1997 9:38:00 AM
From: Jonathan Rothschild   of 170
 
This stock looks like it's finally breaking out. Remember, they recently did a placement at $3 and are still profitable, so they're book value went up. The stock may have been weak due to uncertainty regarding the passing away of the chairman. I understand that much of their revenues come from abroad where they don't have to deal with the FDA. The PSA test results will make this stock pop in a day and people will have wished they had bought in at these prices. The Lancer division is finally turning around; it has been the biggest drag on earnings. Without it, the company would earn over 40 cents per year. Also, Hemagen was up 30% yesterday, which operates in a somewhat similar sector. It could be that the microcap diagnostic cos. are attracting momentum players.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext